Remed Co.Ltd (302550) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.006x

Based on the latest financial reports, Remed Co.Ltd (302550) has a cash flow conversion efficiency ratio of 0.006x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩238.69 Million ≈ $161.76K USD) by net assets (₩39.24 Billion ≈ $26.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Remed Co.Ltd (302550) balance sheet quality index to measure how much of total assets are equity-financed.

Remed Co.Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Remed Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Remed Co.Ltd to evaluate the quality of earnings relative to operating cash generation.

Remed Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Remed Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kanpur Plastipack Limited NSE:KANPRPLA	0.057x
G5 Entertainment publ AB ST:G5EN	-0.006x
Cross Timbers Royalty Trust NYSE:CRT	1.984x
2S Metal Public Company Limited BK:2S	0.007x
Mobiis Co. Ltd KQ:250060	0.010x
Orexo AB ST:ORX	-0.091x
MFO SA WAR:MFO	0.062x
Choheung KO:002600	0.180x

Annual Cash Flow Conversion Efficiency for Remed Co.Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Remed Co.Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Remed Co.Ltd (302550) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩39.46 Billion ≈ $26.74 Million	₩2.40 Billion ≈ $1.62 Million	0.061x	+96.37%
2024-12-31	₩40.25 Billion ≈ $27.28 Million	₩1.24 Billion ≈ $843.40K	0.031x	-72.79%
2023-12-31	₩30.79 Billion ≈ $20.87 Million	₩3.50 Billion ≈ $2.37 Million	0.114x	-34.77%
2022-12-31	₩29.92 Billion ≈ $20.28 Million	₩5.21 Billion ≈ $3.53 Million	0.174x	+230.28%
2021-12-31	₩26.10 Billion ≈ $17.69 Million	₩-3.49 Billion ≈ $-2.36 Million	-0.134x	-227.93%
2020-12-31	₩24.79 Billion ≈ $16.80 Million	₩2.59 Billion ≈ $1.76 Million	0.105x	-20.14%
2019-12-31	₩24.62 Billion ≈ $16.69 Million	₩3.22 Billion ≈ $2.18 Million	0.131x	+550.48%
2018-12-31	₩10.94 Billion ≈ $7.42 Million	₩-317.96 Million ≈ $-215.48K	-0.029x	-282.16%
2017-12-31	₩4.19 Billion ≈ $2.84 Million	₩66.75 Million ≈ $45.24K	0.016x	--

About Remed Co.Ltd

KQ:302550 Korea Medical Devices

Market Cap

$54.78 Million

₩80.83 Billion KRW

Market Cap Rank

#21497 Global

#1239 in Korea

Share Price

₩2670.00

Change (1 day)

+2.50%

52-Week Range

₩2485.00 - ₩3985.00

All Time High

₩4180.00